The research findings primarily focus on individuals with a sleep disorder but may have broader implications. A recent study ...

CervoMed's Phase 2b study extension shows improved cognitive outcomes with neflamapimod, leading to an analyst upgrade and ...

This unexpected early warning sign relates to a change in sensory perception, specifically your sense of smell. A declining ...

For people with a certain sleep disorder, a simple blood test could help predict the development of dementia years before ...

CervoMed has announced positive results from the extension phase 2b RewinD-LB study of neflamapimod for dementia with Lewy ...

For people with a certain sleep disorder, a simple blood test could help predict the development of dementia years before symptoms appear, a new study indicates. Idiopathic REM sleep behavior disorder ...

Researchers at McGill University found that a blood test originally designed for Alzheimer’s can predict dementia risk in ...

A new batch of neflamapimod capsules led to increased plasma drug concentrations and demonstrated improvement (p<0.001 vs. old capsules; ...

Hospice use varies depending on whether a person has Parkinson’s disease, Lewy body dementia or Alzheimer’s disease and those with Parkinson’s may have more unmet needs, a new study finds.

“Project Preserve has demonstrated exceptional foresight and dedication in educating students about brain health and dementia ...